ArticleJournal of cancer research and clinical oncology2011

Combined treatment with TRAIL and PPARγ ligands overcomes chemoresistance of ovarian cancer cell lines.

Karen Bräutigam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.